The frequency with which 7 of the largest Medicare Advantage plans impose step therapy protocols in their Part B drug coverage decisions varies substantially. Objectives: First, to examine 7 large ...
The Centers for Medicare & Medicaid Services (CMS) recently announced its decision to allow Medicare Advantage organizations (MAOs) to implement step therapy for Part B drugs and services beginning ...
The Trump administration will allow Medicare Advantage plans to negotiate prices for Part B drugs by providing them the opportunity to create plans that utilize step therapy. However, some in the ...
UnitedHealthcare's Mike Anderson says CMS' step therapy guidance could grow the biosimilars market and generate significant savings for members. (UnitedHealth Group) A recent policy change that would ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results